Physician

Alok K Srivastava, MD

According to 2025 Medicare claims, Alok Srivastava, MD (NPI: 1568418937) practices internal medicine in the Racine-Mount Pleasant, WI market, with the plurality of this provider's patient population coming from Racine, WI. This provider's primary affiliated billing organization is AURORA MEDICAL GROUP, INC. (NPI: 1427271378; TIN: 391678306) and primary practice location at 53185-4577. Srivastava is affiliated with the Advocate Physician Partners Accountable Care, Inc. (ACO ID: A1033), Collaborative ACO 30, LLC (ACO ID: A5483), and Accountable Care Organization of Advocate Aurora Health, LLC (ACO ID: D0260), participating under both the MSSP and REACH models.

Srivastava's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 238 traditional Medicare patients, billed 1,152 HCPCS/CPT codes, and received $89,891 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 9,130 prescription claims across 593 beneficiaries totaling $669,348 in drug costs, led by Eliquis (Apixaban). DME data shows 85 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $476,424 to $669,348. In contrast, DME billing represents a smaller volume and moved from a lower plateau to a higher plateau, from $8,141 to $15,994.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$53K$105K2015 Medicare payment: $90,782 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $105,295 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $84,503 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $88,108 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $79,944 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $65,442 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $74,202 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $79,753 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $84,272 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $89,891 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153402,658$90,782
20163312,372$105,295
20172931,435$84,503
20182801,443$88,108
20192541,260$79,944
20202331,003$65,442
2021231944$74,202
20222551,028$79,753
20232351,094$84,272
20242381,152$89,891

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$399K$798K2015 Drug cost: $476,424 (USD; Tot_Drug_Cst)2016 Drug cost: $446,280 (USD; Tot_Drug_Cst)2017 Drug cost: $493,930 (USD; Tot_Drug_Cst)2018 Drug cost: $518,034 (USD; Tot_Drug_Cst)2019 Drug cost: $479,390 (USD; Tot_Drug_Cst)2020 Drug cost: $487,720 (USD; Tot_Drug_Cst)2021 Drug cost: $565,326 (USD; Tot_Drug_Cst)2022 Drug cost: $689,407 (USD; Tot_Drug_Cst)2023 Drug cost: $797,793 (USD; Tot_Drug_Cst)2024 Drug cost: $669,348 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154018,457$476,424
20163698,463$446,280
20173918,722$493,930
20184038,394$518,034
20194018,011$479,390
20204217,446$487,720
20214677,182$565,326
20225497,813$689,407
20235738,896$797,793
20245939,130$669,348

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$6.9K$14K2015 Medicare payment: $7,575 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $4,330 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $1,874 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $3,222 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $4,852 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $5,083 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $8,298 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $4,415 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $9,204 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $13,775 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
201544223$7,575
201661211$4,330
201739133$1,874
201850193$3,222
201939228$4,852
202021135$5,083
202118125$8,298
20221881$4,415
202317112$9,204
20241485$13,775

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
G0439Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit168168$121
90662Influenza vaccine split virus, preservative free6970$81
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more199362$76
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more91128$54
G0008Administration of influenza virus vaccine7982$30

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EliquisApixaban925,656$111,131
JanuviaSitagliptin Phosphate854,522$81,741
TrulicityDulaglutide481,820$65,862
JardianceEmpagliflozin302,411$48,483
XareltoRivaroxaban541,927$36,315

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
A4239Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of serviceNN/R21$12,102
E1390Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rateYN/R12$810
A4253Blood glucose test or reagent strips for home blood glucose monitor, per 50 stripsN1440$486
E1392Portable oxygen concentrator, rentalYN/R12$377

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Alok K. Srivastava, MD?

Tedicare shows public-source Medicare data for Alok K. Srivastava, MD (NPI 1568418937), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alok K. Srivastava, MD have ACO affiliation data?

Alok K. Srivastava, MD is shown with ACO affiliation data for Advocate Physician Partners Accountable Care, Inc. (MSSP, ACO ID A1033), Collaborative ACO 30, LLC (MSSP, ACO ID A5483), and Accountable Care Organization of Advocate Aurora Health, LLC (REACH, ACO ID D0260).

What billing organization is linked to Alok K. Srivastava, MD?

Alok K. Srivastava, MD is linked to AURORA MEDICAL GROUP, INC. (billing NPI 1427271378) in the available physician profile data.

Does Alok K. Srivastava, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.